HISTORICAL PERSPECTIVE, PATHOPHYSIOLOGY AND BACTERIOLOGY OF PLEURAL
INFECTION This section provides background information for reference, interest and to set …

Venous thromboembolism (VTE) is a significant cause of morbidity and mortality in
hospitalized patients. Where appropriate, evidence-based methods of prophylaxis are …

Background: Prophylaxis of venous thromboembolism (VTE) in hospitalized medical
patients is largely underused. We sought to assess the value of a simple risk assessment …

Background: Extended-duration low-molecular-weight heparin has been shown to prevent
venous thromboembolism (VTE) in high-risk surgical patients. Objective: To evaluate the …

INTRODUCTION: In clinical trials, fixed-dose enoxaparin (40 mg once daily) reduces the risk
of venous thromboembolism (VTE) in medically-ill patients. However, morbidly obese …

Thanks to their predictable pharmacokinetics and ease of use, low-molecular-weight
heparins (LMWHs) have established uses in the prevention and treatment of thrombotic …

Congestive heart failure (CHF) is a medical condition associated with a relatively high risk of
venous thromboembolism (VTE). Without thromboprophylaxis, venographically proven deep …

Venous thromboembolism (VTE) is a serious and potentially fatal disorder, which is often
associated with a significant impact on the quality of life and on the clinical outcome of …

The risk of venous thromboembolism (VTE) is substantially increased in cancer patients [1–
3]. The risk of VTE in cancer patients is also increased in those hospitalized, the elderly, and …

Study Design. A survey on thromboprophylaxis in spinal surgery and trauma was conducted
among spine trauma surgeons. Objective. Neurosurgeons and orthopedic surgeons from the …